Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Intestinal Diseases 5Constipation 5Pain 3Neoplasms 2Ovarian Neoplasms 1Opioid-Induced Constipation 1Fallopian Tube Neoplasms 1Cancer Pain 1

Interventions

naloxegol 6linaclotide 1alvimopan 1Electroacupuncture 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Opioid-Induced Constipation × alvimopan × Clear all
NCT00135577 2015-09-02

Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Phase 2 Completed
67 enrolled
Other

Opioid-Induced Constipation, Constipation, Intestinal Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡